Cohort PLC Company Profile (LON:CHRT)

About Cohort PLC

Cohort PLC logoCohort plc is a holding company. The Company's segments include MASS, MCL, SCS and SEA. Its subsidiaries include Systems Consultants Services Limited (SCS) and SEA (Group) Ltd. (SEA). Its sub-subsidiaries include MASS Consultants Limited (MASS) and Marlborough Communications Limited (MCL). SCS is a defense consultancy. SEA is an electronic systems and software company operating in the defense, transport and offshore energy markets. MASS is a specialist defense and technology business, focused on electronic warfare, information systems and cyber security. MCL is engaged in sourcing, design, integration and support of communications and surveillance technology for the defense and security markets. It provides a range of services and products for the United Kingdom, Portugal and international customers in defense and related markets. The Company operates in the United Kingdom, other European Community (EC) countries, Asia Pacific, and North and South America.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: CHRT
  • CUSIP:
Key Metrics:
  • Previous Close: $4.24
  • 50 Day Moving Average: $320.89
  • 200 Day Moving Average: $343.24
  • 52-Week Range: £402,030 - GBX 276
  • Trailing P/E Ratio: 18.48
  • P/E Growth: 0.00
  • Market Cap: $142.33B
  • Outstanding Shares: 40,203,000
Additional Links:

Analyst Ratings

Consensus Ratings for Cohort PLC (LON:CHRT) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: GBX 420

Analysts' Ratings History for Cohort PLC (LON:CHRT)
DateFirmActionRatingPrice TargetDetails
10/6/2016Canaccord GenuityReiterated RatingBuyGBX 420View Rating Details
9/10/2015Panmure GordonBoost Price TargetBuyGBX 300 -> GBX 420View Rating Details
8/13/2015InvestecBoost Price TargetBuyGBX 400 -> GBX 420View Rating Details
(Data available from 10/24/2014 forward)


Earnings History for Cohort PLC (LON:CHRT)
No earnings announcements for this company have been tracked by


Earnings Estimates for Cohort PLC (LON:CHRT)
Current Year EPS Consensus Estimate: $25.37 EPS


Dividend History for Cohort PLC (LON:CHRT)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/28/2016GBX 4.101.36%8/25/20168/25/20169/21/2016
12/14/2015GBX 1.900.47%2/4/20162/4/20163/2/2016
6/25/2015GBX 3.401.19%8/27/20158/27/20159/30/2015
12/15/2014GBX 1.600.67%2/5/20152/5/20153/4/2015
6/26/2014GBX 2.801.37%8/27/20148/27/20149/24/2014
12/16/2013GBX 1.400.72%2/5/20142/5/20143/5/2014
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Cohort PLC (LON:CHRT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/15/2016Thomis,Andrew StephenInsiderBuy26GBX 390£101.40
4/13/2016Walther,SimonInsiderBuy8,040GBX 372£29,908.80
4/12/2016Thomis,Andrew StephenInsiderBuy2,350GBX 376£8,836
4/11/2016Thomis,Andrew StephenInsiderSell218,541GBX 375£819,528.75
2/9/2016Walmsley,Sir RobertInsiderBuy4,965GBX 332£16,483.80
12/15/2015Perrin,Jeffrey LawrenceInsiderBuy4,000GBX 390£15,600
(Data available from 1/1/2013 forward)


Latest Headlines for Cohort PLC (LON:CHRT)
DateHeadline logoReorganisation at SCS (LON:CHRT) - October 11 at 4:21 PM logoCohort Plc breached its 50 day moving average in a Bullish Manner : CHRT-GB : October 10, 2016 (LON:CHRT) - October 10 at 8:58 AM logoEQS-News: Edison issues outlook on Cohort (CHRT) (LON:CHRT) - October 4 at 4:12 PM logoDirector Share Options (LON:CHRT) - August 31 at 8:59 AM logoDirector Share Awards, Options and Shareholdings (LON:CHRT) - August 16 at 4:17 PM logoCohort Plc breached its 50 day moving average in a Bearish Manner : CHRT-GB : August 9, 2016 (LON:CHRT) - August 9 at 12:01 PM logoCohort Plc – Value Analysis (LONDON:CHRT) : July 19, 2016 (LON:CHRT) - July 19 at 2:33 PM logoCohort Plc breached its 50 day moving average in a Bullish Manner : CHRT-GB : July 13, 2016 (LON:CHRT) - July 13 at 4:40 AM logoCritical Outcome Initiates Third Cohort in Phase 1 Study of COTI-2 in Gynecologic Cancers (LON:CHRT) - July 12 at 9:23 AM logoIndustry Center - Aerospace/Defense - Major Diversified (LON:CHRT) - June 29 at 9:15 PM logoShould you buy, sell or hold Ocado Group plc, Carpetright plc and Cohort plc on today’s results? (LON:CHRT) - June 28 at 7:59 AM logoFull Year 2016 Cohort PLC Earnings Release - Before Market Open (LON:CHRT) - June 28 at 7:07 AM logoSerodus announces that the first patient is randomized into the second cohort of the SER150 Ph2a study in Diabetic Nephropathy (LON:CHRT) - June 20 at 3:49 AM logoSerodus announces initiation of second cohort in Ph2a study of SER150 in Diabetic Nephropathy (LON:CHRT) - June 1 at 3:43 AM logoCohort Analysis: Its Full Potential (LON:CHRT) - May 26 at 4:17 AM logoCohort Plc breached its 50 day moving average in a Bearish Manner : CHRT-GB : May 23, 2016 (LON:CHRT) - May 23 at 4:45 AM logoCohort Plc : Undervalued relative to peers, but don’t ignore the other factors (LON:CHRT) - February 12 at 4:10 PM logoPositive safety of first cohort in Progenza stem cell trial for knee osteoarthritis (LON:CHRT) - January 11 at 5:59 PM logoCohort Plc Earnings Analysis: H1, 2015 By the Numbers (LON:CHRT) - January 2 at 7:18 PM logoWould You Head Back Home If You Forgot Your Wallet? Your Keys? Your Apple Watch? (LON:CHRT) - December 18 at 8:00 AM logoCohort Plc breached its 50 day moving average in a Bearish Manner : December 16, 2015 (LON:CHRT) - December 16 at 4:32 AM logoCohort reports 40% jump in half year operating profit (LON:CHRT) - December 14 at 11:08 AM logoHelix BioPharma Corp. Initiates Enrollment for Fourteenth Cohort in Polish Phase I/II Clinical Study of Its L-DOS47 Lung Cancer Drug (LON:CHRT) - November 19 at 12:30 PM logoCohort subsidiary wins GBP3m support services contract (LON:CHRT) - October 12 at 8:03 PM logoCohort clinches EUR19m deal for EID (LON:CHRT) - August 5 at 5:48 AM logoUltimi risultati relativi alla valvola Perceval, presentati in occasione del 95° congresso dell’American Association of Thoracic Surgery (LON:CHRT) - April 30 at 11:47 AM logoPROTALEX ANNOUNCES FINDINGS FROM FINAL COHORT OF U.S. PHASE 1b TRIAL OF PRTX-100 IN ACTIVE RHEUMATOID ARTHRITIS PATIENTS (LON:CHRT) - April 16 at 9:56 AM


Last Updated on 10/24/2016 by Staff